361 related articles for article (PubMed ID: 30414835)
1. Role of adenomatous polyposis coli (APC) gene mutations in the pathogenesis of colorectal cancer; current status and perspectives.
Aghabozorgi AS; Bahreyni A; Soleimani A; Bahrami A; Khazaei M; Ferns GA; Avan A; Hassanian SM
Biochimie; 2019 Feb; 157():64-71. PubMed ID: 30414835
[TBL] [Abstract][Full Text] [Related]
2. Adenomatous polyposis coli (APC) membrane recruitment 3, a member of the APC membrane recruitment family of APC-binding proteins, is a positive regulator of Wnt-β-catenin signalling.
Brauburger K; Akyildiz S; Ruppert JG; Graeb M; Bernkopf DB; Hadjihannas MV; Behrens J
FEBS J; 2014 Feb; 281(3):787-801. PubMed ID: 24251807
[TBL] [Abstract][Full Text] [Related]
3. Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis.
Gaspar C; Cardoso J; Franken P; Molenaar L; Morreau H; Möslein G; Sampson J; Boer JM; de Menezes RX; Fodde R
Am J Pathol; 2008 May; 172(5):1363-80. PubMed ID: 18403596
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
5. Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis.
Hu PJ; Knoepp SM; Wu R; Cho KR
Genes Chromosomes Cancer; 2012 Mar; 51(3):283-9. PubMed ID: 22120905
[TBL] [Abstract][Full Text] [Related]
6. The effect of a germline mutation in the APC gene on β-catenin in human embryonic stem cells.
Yedid N; Kalma Y; Malcov M; Amit A; Kariv R; Caspi M; Rosin-Arbesfeld R; Ben-Yosef D
BMC Cancer; 2016 Dec; 16(1):952. PubMed ID: 28010732
[TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer.
Ruiz-Ponte C; Vega A; Carracedo A; Barros F
Hum Mutat; 2001 Oct; 18(4):355. PubMed ID: 11668620
[TBL] [Abstract][Full Text] [Related]
8. Molecular drivers of tumor progression in microsatellite stable APC mutation-negative colorectal cancers.
Grant A; Xicola RM; Nguyen V; Lim J; Thorne C; Salhia B; Llor X; Ellis N; Padi M
Sci Rep; 2021 Dec; 11(1):23507. PubMed ID: 34873211
[TBL] [Abstract][Full Text] [Related]
9. USP7 Is a Tumor-Specific WNT Activator for APC-Mutated Colorectal Cancer by Mediating β-Catenin Deubiquitination.
Novellasdemunt L; Foglizzo V; Cuadrado L; Antas P; Kucharska A; Encheva V; Snijders AP; Li VSW
Cell Rep; 2017 Oct; 21(3):612-627. PubMed ID: 29045831
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.
Segditsas S; Sieber OM; Rowan A; Setien F; Neale K; Phillips RK; Ward R; Esteller M; Tomlinson IP
Exp Mol Pathol; 2008 Dec; 85(3):201-6. PubMed ID: 18977219
[TBL] [Abstract][Full Text] [Related]
11. Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer.
Zhang L; Shay JW
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28423402
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC).
Hammoudi A; Song F; Reed KR; Jenkins RE; Meniel VS; Watson AJ; Pritchard DM; Clarke AR; Jenkins JR
Biochem Biophys Res Commun; 2013 Oct; 440(3):364-70. PubMed ID: 23998936
[TBL] [Abstract][Full Text] [Related]
13. Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.
Groves C; Lamlum H; Crabtree M; Williamson J; Taylor C; Bass S; Cuthbert-Heavens D; Hodgson S; Phillips R; Tomlinson I
Am J Pathol; 2002 Jun; 160(6):2055-61. PubMed ID: 12057910
[TBL] [Abstract][Full Text] [Related]
14. [Mutational studies of adenomatous polyposis coli gene in carcinomas from patients with hereditary non-polyposis colorectal cancers].
Huang J; Jin SH; Zhang SZ; Zheng S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):196-9. PubMed ID: 12778442
[TBL] [Abstract][Full Text] [Related]
15. Novel strategies for comprehensive mutation screening of the APC gene.
Wachsmannova L; Mego M; Stevurkova V; Zajac V; Ciernikova S
Neoplasma; 2017; 64(3):338-343. PubMed ID: 28253712
[TBL] [Abstract][Full Text] [Related]
16. Expression and mutation pattern of β-catenin and adenomatous polyposis coli in colorectal cancer patients.
Abdelmaksoud-Damak R; Miladi-Abdennadher I; Triki M; Khabir A; Charfi S; Ayadi L; Frikha M; Sellami-Boudawara T; Mokdad-Gargouri R
Arch Med Res; 2015 Jan; 46(1):54-62. PubMed ID: 25660336
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic mutations in adenomatous polyposis coli (Apc) activate mechanistic target of rapamycin complex 1 (mTORC1) in mice and zebrafish.
Valvezan AJ; Huang J; Lengner CJ; Pack M; Klein PS
Dis Model Mech; 2014 Jan; 7(1):63-71. PubMed ID: 24092877
[TBL] [Abstract][Full Text] [Related]
18. A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC.
Schell MJ; Yang M; Teer JK; Lo FY; Madan A; Coppola D; Monteiro AN; Nebozhyn MV; Yue B; Loboda A; Bien-Willner GA; Greenawalt DM; Yeatman TJ
Nat Commun; 2016 Jun; 7():11743. PubMed ID: 27302369
[TBL] [Abstract][Full Text] [Related]
19. APC germline mutations in individuals being evaluated for familial adenomatous polyposis: a review of the Mayo Clinic experience with 1591 consecutive tests.
Kerr SE; Thomas CB; Thibodeau SN; Ferber MJ; Halling KC
J Mol Diagn; 2013 Jan; 15(1):31-43. PubMed ID: 23159591
[TBL] [Abstract][Full Text] [Related]
20. Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis.
Takane K; Matsusaka K; Ota S; Fukuyo M; Yue Y; Nishimura M; Sakai E; Matsushita K; Miyauchi H; Aburatani H; Nakatani Y; Takayama T; Matsubara H; Akagi K; Kaneda A
Oncotarget; 2016 Dec; 7(51):84003-84016. PubMed ID: 27563825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
